Disease management
Swing Therapeutics CEO Mike Rosenbluth discusses the company's fibromyalgia management tool and what's necessary to make digital therapeutics mainstream.
The collaboration comes weeks after Happify announced a partnership with insurer Anthem on a women's health product.
Both RetiKid and RetiAge use AI deep learning algorithms to screen for health conditions in retinal images.
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
It will use the funds to deepen its presence across Asia.
The company has also launched a distribution unit in the United States.
The StrivePD app uses Apple's Movement Disorder API to track tremors and uncontrolled body movement.
Also: Healthcare professional networking and data platform H1 adds another $23 million to its Series C round, and chronic condition management company DarioHealth secures a loan facility of up to $50 million.
The company is also close to getting its patent for the Us2.v1 software recognised in the US.
They will provide the first access to an AI-enabled minimal residual disease test in India.